Flower power can still calm the masses

Feb 09, 2010

Feeling stressed? Try chamomile! This 'traditional' remedy has been around for years, but how much truth is there behind this old wives' tale?

In an evaluation for Faculty of 1000, Michael Van Ameringen and Beth Patterson draw attention to the first of chamomile for the treatment of (GAD).

The study, recently published in the Journal of Clinical Psychopharmacology, reports that "chamomile extract therapy was found to be efficacious for mild-moderate GAD".

Patients with mild-moderate GAD were included in the study and received either chamomile or . Those that received the chamomile treatment were found to have a significant change in the severity of their GAD.

Van Amerigen and Patterson comment on the results of the study, saying that they "suggest that chamomile may have modest [anti-panic] activity in patients with mild-moderate GAD and may potentially be used in those who are averse to traditional ".

These findings are important "because many individuals who suffer from GAD do not view their anxiety as a medical condition, [and, therefore,] self-diagnosis and self-medicating with alternative, over-the-counter remedies is common".

Van Amerigen and Patterson said "a big strength of this paper is that the authors took a herbal remedy and subjected it to scientific rigor unlike many 'natural' remedies which have associated claims of efficacy with no supportive data."

Explore further: FDA approves hard-to-abuse narcotic painkiller

Provided by Faculty of 1000: Biology and Medicine

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Anxiety disorders surprisingly common yet often untreated

Mar 12, 2007

A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

6 hours ago

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

6 hours ago

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

7 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

7 hours ago

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments : 0